Syphilis Becomes China’s Most Common STI, Especially Among Infants

After being nearly eradicated in China 50 years ago, syphilis has become the most commonly reported sexually transmitted infection in Shanghai, the nation’s largest city, the AP/Yahoo! News reports. According to a commentary published Thursday in the New England Journal of Medicine, an average of one infant with congenital syphilis is born every hour in [...]

Ob-Gyns To Meet In San Francisco For 58th Annual Clinical Meeting

Obstetrician-gynecologists from across the US and around the world will convene May 15-19 at The American College of Obstetricians and Gynecologists’ 58th Annual Clinical Meeting (ACM) in San Francisco at The Moscone Center. News releases and video briefs from researchers and key speakers will be posted daily during the ACM beginning on Monday, May 17 [...]

Women’s Rights Advocates Urge Boycott Of Cancun In Protest Of Mexican Abortion Laws

Reproductive-rights groups in Mexico Thursday launched a campaign urging international tourists to boycott the Mexican resort city of Cancun, saying officials there failed to protect the rights of a pregnant 11-year-old who says she was raped by her stepfather, the AP/MSNBC reports…

HHS Outlines Rule for Young Adult Health Coverage

WASHINGTON –The U.S. Department of Health and Human Services has issued an interim final rule implementing a requirement that insurers who offer dependent coverage allow children to remain on their parents’ policies until at least age 26.

Cancer Costs Double in Less than 20 Years (CME/CE)

Over a period of nearly two decades, the medical costs of cancer care almost doubled, researchers said.

Alexza Pharmaceuticals first-quarter net loss increases to $13.4 million

Alexza Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010 and provided a business update.

CrystalGenomics completes European Phase I SAD study of CG400549 antibiotic candidate

CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe.

Generex Biotechnology enrolls over 400 subjects in global Phase III study of Generex Oral-lyn

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has achieved enrolled of over 400 subjects in its pivotal global Phase III study of its flagship product, Generex Oral-lyn™, a proprietary buccal insulin spray product designed to replace prandial injections of insulin.

Enzon reports income from continuing operations of $20.8M for first-quarter 2010

Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.

QRxPharma reports successful outcome of Phase 1 trial for MoxDuo CR for chronic pain

QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental [...]